{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:29:47Z","timestamp":1792211387511,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12325-023-02563-5","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T01:02:35Z","timestamp":1688691755000},"page":"3986-4003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US"],"prefix":"10.1007","volume":"40","author":[{"given":"Michael","family":"Hull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-8657","authenticated-orcid":false,"given":"Vamshi Ruthwik","family":"Anupindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-6202","authenticated-orcid":false,"given":"Mitchell","family":"DeKoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-1847","authenticated-orcid":false,"given":"Jonathan","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"2563_CR1","first-page":"401","volume":"46","author":"O Simon","year":"2010","unstructured":"Simon O, Yelnik AP. Managing spasticity with drugs. Eur J Phys Rehabil Med. 2010;46:401.","journal-title":"Eur J Phys Rehabil Med"},{"key":"2563_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/354906","volume":"2014","author":"C Trompetto","year":"2014","unstructured":"Trompetto C, Marinelli L, Mori L, Pelosin E, Curr\u00e0 A, Molfetta L, et al. Pathophysiology of spasticity: implications for neurorehabilitation. Biomed Res Int. 2014;2014:1.","journal-title":"Biomed Res Int"},{"key":"2563_CR3","unstructured":"Pandey K. Spasticity: practice essentials, background, pathophysiology [Internet]. 2019 [cited 2022 Mar 21]. Available from: https:\/\/emedicine.medscape.com\/article\/2207448-overview"},{"key":"2563_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.566124","volume":"11","author":"H Zeng","year":"2020","unstructured":"Zeng H, Chen J, Guo Y, Tan S. Prevalence and risk factors for spasticity after stroke: a systematic review and meta-analysis. Front Neurol. 2020;11:1.","journal-title":"Front Neurol"},{"key":"2563_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40271-016-0173-0","volume":"9","author":"F Bethoux","year":"2016","unstructured":"Bethoux F, Marrie RA. A cross-sectional study of the impact of spasticity on daily activities in multiple sclerosis. Patient. 2016;9:537.","journal-title":"Patient"},{"key":"2563_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.apmr.2016.09.124","volume":"98","author":"KA Holtz","year":"2017","unstructured":"Holtz KA, Lipson R, Noonan VK, Kwon BK, Mills PB. Prevalence and effect of problematic spasticity after traumatic spinal cord injury. Arch Phys Med Rehab. 2017;98:1132.","journal-title":"Arch Phys Med Rehab"},{"key":"2563_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/qjmed\/hch105","volume":"97","author":"L Hemmett","year":"2004","unstructured":"Hemmett L, Holmes J, Barnes M, Russell N. What drives quality of life in multiple sclerosis? QJM. 2004;97:671.","journal-title":"QJM"},{"key":"2563_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1542\/peds.2007-1270","volume":"121","author":"M Yeargin-Allsopp","year":"2008","unstructured":"Yeargin-Allsopp M, Van Braun KN, Doernberg NS, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the united states in 2002: a multisite collaboration. Pediatrics. 2008;121:547.","journal-title":"Pediatrics"},{"key":"2563_CR9","first-page":"1","volume":"2014","author":"R Bhimani","year":"2014","unstructured":"Bhimani R, Anderson L. Clinical understanding of spasticity: implications for practice. Rehabil Res Pract. 2014;2014:1.","journal-title":"Rehabil Res Pract"},{"key":"2563_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.hcl.2018.06.001","volume":"34","author":"FJ Angulo-Parker","year":"2018","unstructured":"Angulo-Parker FJ, Adkinson JM. Common etiologies of upper extremity spasticity. Hand Clin. 2018;34:437.","journal-title":"Hand Clin"},{"key":"2563_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fneur.2020.00388","volume":"11","author":"J Jacinto","year":"2020","unstructured":"Jacinto J, Varriale P, Pain E, Lysandropoulos A, Esquenazi A. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in spasticity. Front Neurol. 2020;11:388.","journal-title":"Front Neurol"},{"key":"2563_CR12","unstructured":"NICE. Spasticity in children and young people with non-progressive brain disorders: management of spasticity and co-existing motor disorders and their early musculoskeletal complications. National Institute for Health and Clinical Excellence Guideline. 2012."},{"key":"2563_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1468-1331.2010.03128.x","volume":"17","author":"J Olver","year":"2010","unstructured":"Olver J, Esquenazi A, Fung VSC, Singer BJ, Ward AB. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. Eur J Neurol. 2010;17:57.","journal-title":"Eur J Neurol."},{"key":"2563_CR14","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2165\/00003495-200161130-00004","volume":"61","author":"M Velickovic","year":"2001","unstructured":"Velickovic M, Benabou R, Brin MF. Cervical dystonia: pathophysiology and treatment options. Drugs. 2001;61:1921.","journal-title":"Drugs"},{"key":"2563_CR15","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86:1818.","journal-title":"Neurology"},{"key":"2563_CR16","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Movement Disorders. 2012;27:1789.","journal-title":"Movement Disorders"},{"key":"2563_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1212\/CPJ.0000000000000568","volume":"9","author":"A Castagna","year":"2019","unstructured":"Castagna A, Albanese A. Management of cervical dystonia with botulinum neurotoxins and EMG\/ultrasound guidance. Neurol Clin Pract. 2019;9:64.","journal-title":"Neurol Clin Pract"},{"key":"2563_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mdc3.12238","volume":"3","author":"ES Molho","year":"2016","unstructured":"Molho ES, Stacy M, Gillard P, Charles D, Adler CH, Jankovic J, et al. Impact of cervical dystonia on work productivity: an analysis from a patient registry. Mov Disord Clin Pract. 2016;3:130.","journal-title":"Mov Disord Clin Pract"},{"key":"2563_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13760-016-0634-1","volume":"116","author":"S Tomic","year":"2016","unstructured":"Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T. Cervical dystonia and quality of life. Acta Neurol Belg. 2016;116:589.","journal-title":"Acta Neurol Belg"},{"key":"2563_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","volume":"72","author":"Y Ben-Shlomo","year":"2002","unstructured":"Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry. 2002;72:608.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2563_CR21","first-page":"1","volume":"2019","author":"LC Sun","year":"2019","unstructured":"Sun LC, Chen R, Fu C, Chen Y, Wu Q, Chen R, et al. Efficacy and safety of botulinum toxin type a for limb spasticity after stroke: a meta-analysis of randomized controlled trials. Biomed Res Int. 2019;2019:1.","journal-title":"Biomed Res Int"},{"key":"2563_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jns.2016.10.005","volume":"371","author":"RL Rosales","year":"2016","unstructured":"Rosales RL, Efendy F, Teleg ES, Delos Santos MM, Rosales MC, Ostrea M, et al. Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: a meta-analysis. J Neurol Sci. 2016;371:6.","journal-title":"J Neurol Sci"},{"key":"2563_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","volume":"8","author":"AMO Bakheit","year":"2001","unstructured":"Bakheit AMO, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol. 2001;8:559.","journal-title":"Eur J Neurol"},{"key":"2563_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11910-014-0463-7","volume":"14","author":"MH Cameron","year":"2014","unstructured":"Cameron MH, Bethoux F, Davis N, Frederick M. Botulinum toxin for symptomatic therapy in multiple sclerosis. Curr Neurol Neurosci Rep. 2014;14:463.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2563_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/16501977-2835","volume":"53","author":"LT Stokes","year":"2021","unstructured":"Stokes LT, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, et al. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin a: findings from the prospective, observational upper limb international spasticity (ulis-iii) cohort study. J Rehabil Med. 2021;53:1.","journal-title":"J Rehabil Med"},{"key":"2563_CR26","first-page":"725","volume":"9","author":"RR Mills","year":"2015","unstructured":"Mills RR, Pagan FL. Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A. Patient Prefer Adherence. 2015;9:725.","journal-title":"Patient Prefer Adherence"},{"key":"2563_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40734-020-0083-0","volume":"7","author":"VP Misra","year":"2020","unstructured":"Misra VP, Danchenko N, Maisonobe P, Lundkvist J, Hunger M. Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia. J Clin Mov Disord. 2020;7:2.","journal-title":"J Clin Mov Disord"},{"key":"2563_CR28","first-page":"817","volume":"25","author":"S Pulgar","year":"2019","unstructured":"Pulgar S, Bains S, Gooch J, Chambers H, Noritz GH, Wright E, et al. Prevalence, patterns, and cost of care for children with cerebral palsy enrolled in medicaid managed care. J Manag Care Spec Pharm. 2019;25:817.","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02563-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:18:34Z","timestamp":1692112714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02563-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2563"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02563-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}